Pantoprazol Omnicals (Pantoprazole Sodium Sesquihydrate)

Pantoprazole sodium sesquihydrate, the active ingredient in Pantoprazol Omnicals, is a proton pump inhibitor presented as a tablet for oral use. It reduces stomach acid production and is used to treat acid‑related gastrointestinal conditions in adults and children.

GNH USA supplies Pantoprazol Omnicals as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Pantoprazol Omnicals is a proton pump inhibitor that acts on the gastric acid secretion pathway. It is indicated for several acid‑related disorders: - Gastro‑oesophageal reflux disease (GERD): provides relief of heartburn and promotes healing of the oesophageal lining. - Erosive oesophagitis: accelerates healing of erosive lesions in the oesophagus. - Peptic ulcer disease (duoden‑and gastric ulcer): supports ulcer healing and reduces recurrence. - Zollinger‑Ellison syndrome: controls excessive gastric acid secretion associated with this rare endocrine disorder.

Pantoprazol Omnicals may cause adverse reactions, most of which are mild and reversible.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhoea: loose stools occurring during early treatment. - Nausea: occasional feeling of stomach upset. - Abdominal pain: cramp‑like discomfort. - Flatulence: increased intestinal gas. - Constipation: reduced bowel movements.

Serious or Rare Side Effects: - Clostridioides difficile infection: severe colitis presenting with watery diarrhoea. - Acute interstitial nephritis: kidney inflammation with reduced urine output. - Severe hypersensitivity: rash, itching, swelling, or anaphylaxis. - Osteoporosis‑related fractures: increased risk of hip or vertebral fractures with long‑term use. - Low magnesium (hypomagnesemia): muscle cramps, irregular heartbeat, or seizures.

When prescribing Pantoprazol Omnicals, clinicians should consider several safety aspects: - Renal impairment: dose adjustment may be required in patients with reduced kidney function. - Hepatic impairment: use with caution in moderate to severe liver disease. - Long‑term therapy: monitor bone health and magnesium levels during prolonged use. - Drug‑induced nutrient absorption: be aware of reduced absorption of vitamin B12 and iron. - Pregnancy and lactation: evaluate risk‑benefit ratio before use. - Store at ambient temperature: keep below 25°C, in the original packaging, protected from moisture.

Pantoprazole can interact with several medicines, altering their effectiveness or safety profile.

Major Interactions (Avoid): - Antifungal agents (ketoconazole, itraconazole): reduced absorption due to higher gastric pH. - HIV protease inhibitors (ritonavir, atazanavir): decreased plasma concentrations. - Clopidogrel: diminished antiplatelet activity.

Moderate Interactions (Monitor Closely): - Warfarin: potential increase in INR. - Methotrexate: reduced renal clearance may raise serum levels. - Digoxin: slight increase in serum concentration. - Oral contraceptives: possible decrease in efficacy.